Clean Science Share Price: Revenue **21%** Gira! China Pressure Aur Margin Squeeze Se Investors Pareshaan?

CHEMICALS
Whalesbook Logo
AuthorVihaan Mehta|Published at:
Clean Science Share Price: Revenue **21%** Gira! China Pressure Aur Margin Squeeze Se Investors Pareshaan?
Overview

Arre bhaiyon, Clean Science ka Q3 FY26 results aa gaya hai aur numbers thode chinta wale hain. Company ka standalone revenue **21%** gir gaya hai YoY, **₹180 crore** pe aa gaya hai. Iske peeche China se badhti competition aur price wars chal raha hai.

📉 Aage Kya Hoga? Numbers Pe Ek Nazar!

Okay, toh jo yeh 21% ki revenue girawat hui hai na, iske peeche kaafi reasons hain. Clean Science and Technology ka Q3 FY26 ka standalone revenue ₹180 crore pe pahuncha hai. Matlab, sales mein tezi nahi, mandi dikhi hai. Aur agar consolidated numbers dekhein toh woh ₹216 crore raha, jo sequential basis par 10% kam hai.

Aur sirf revenue nahi, margins bhi tight ho gaye hain. Standalone EBITDA margin 40% pe aaya hai, aur PAT margin 29%. Consolidated level par dekha toh EBITDA ₹72 crore raha (33% margin) aur PAT ₹46 crore (21% margin). Saaf dikh raha hai ki profitability pe kaafi pressure hai.

Is 9 mahine (FY26) mein standalone revenue 10% kam hokar ₹602 crore ho gaya. Company ne bataya ki cosmetics segment mein ek bade customer ko kho diya aur Agchem sector mein bhi prices ko lekar dikkat hai. Iss wajah se EPS mein bhi -9.57% ka surprise dikh raha hai, matlab analyst expectations miss hue hain.

Achhi baat ye hai ki company ke paas cash ₹450 crore kaafi hai, jo current situation mein madad karega. Aur haan, company ne ₹2 per share ka interim dividend bhi announce kiya hai, jo shareholders ke liye ek chhota sa gift hai.

📉 Market Ki Challenges Aur Future Outlook

Management bhi future ko lekar thoda cautious hai. Unka kehna hai ki ye market ki challenges, jaise China se competition aur pricing pressure, abhi kam se kam 2 aur quarters tak chalne wali hain. Isliye koi specific forward guidance nahi di hai, matlab aage kaafi soch samajh kar chalna padega.

🚀 New Plants Aur Positive Points

Lekin bhai, sab kuch bura hi nahi hai. Company ne December 2025 mein apne naye Hydroquinone aur Catechol plants start kar diye hain, jisse future mein fayda hone ki ummeed hai. Performance Chemical 2 ka kaam bhi chal raha hai, jo Q1 FY27 tak start ho jayega.

Ek positive point ye hai ki HALS business ne 55% YoY growth dikhaya hai. Is segment mein achha performance raha hai aur yeh ek bright spot hai. Clean Fino Chem, jo subsidiary hai, woh bhi breakeven level pe aa gayi hai.

Overall, short term mein toh thoda pressure rahega, par naye plants aur HALS business se long term mein ummeed hai.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.